In our meta-analysis, seven prospective cohort studies including 31545 participants and 2873 cases of MetS, revealed a significant association between ALT activity and risk of MetS in comparisons between the highest versus the lowest category of ALT activity (RR: 1.81, 95% CI: 1.49–2.14, Figure 3). The gene discussed is GPT; the disease is metabolic syndrome.